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ABSTRACT
Some novel symmetric 1,1’-dimethylferrocene derived amino acids have been prepared by the reaction of
1,1’-ferrocenedimethyldichloride with amino acids (glycine, alanine, phenylalanine and tyrosine). Their
Cu(lI), Co(ll) and Ni(II) co,mllexes, of the type [M(L)] where [M=Cu(II) and L=L-L5] and [M(L)CI2] where
[M=Co(II)and Ni(lI), L=L’-L] have been prepared. The dicarboxylic acids and their metal complexes were
characterized by their physical, analytical and spectral data. The [M(L)] complexes showed a square planar
geometry whereas an octahedral geometry was observed for [M(L)CI2] complexes. The title dicarboxylic
acids and their metal complexes have also been screened for their antibacterial activity.
INTRODUCTION
There are significant evidences
1-4 that amino acid complexes are potentially used in the treatment of tumors.
Various tumors tend to have poor blood supplies and therefore, amino acids have been effectively used to
direct nitrogen mustards into the cancer cells. For example, phenylalanine mustard is used in controlling
malignant myeloma and Burkitts’ lymphoma and, similarly sarcolysine is used to treat wide range of
tumors. Indeed, certain tumors and cancer cells are unable to produce all the amino acids synthesized by the
normal cells. Therefore, these cells require an external supply of such essential amino acids to pass on to the
cancer cells by the blood stream.
In the recent past a number of studies
82 have highlighted the utility of ferrocene and its derivatives in
various applications137. Very few ferrocene-derived compounds have been used as ligands for the complex
formation reactions. Keeping in view the significance of amino acids and their complexes as chemotheraptic
agent and the chemistry of ferrocene or ferrocene-containing compounds as stable intermediates, a successful
effort to join the chemistry of amino acids and ferrocene is made. For this purpose, some novel symmetric
1,1’-dimethylferrocene derived amino acids (Figure 1) have been synthesized and studied for their
physicochemical, ligational behavior with Cu(II), Co(II) and Ni(II) metal ions and also for their antibacterial
properties against bacterial strains, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and
Klebsiella pneumonae.
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Fig. 1. Proposed Structure of the Ligands
EXPERIMENTAL
Material and Methods
All solvents were used as Analar grade. 1, l’-Ferrocenedimethanol was obtained from Merck. l,l’-
Ferrocenedimethyldichloride derivative was prepared by a reported method
8 using thionyl chloride in
triethylamine. All metals were used as chlorides. IR, 1H NMR and 13C NMR spectra were recorded on
Philips Analytical PU 9800 FTIR and Brucker 250 MHz instruments. UV- Visible spectra were obtained on a
Hitachi U-2)00 double-beam spectrophotometer. Conductance of the metal complexes was determined in
DMF at 10"- dilution on a YSI-32 model conductometer. Magnetic measurements were done on solid
complexes using the Gouy method. The synthesized dicarboxylic acids and their metal complexes were
analyzed for C, H and N by Butterworth Laboratories Ltd. Melting points were recorded on a Gallenkamp
apparatus and are uncorrected.
Synthesis of Dicarboxylic acids
A mixture of l,l’-ferrocenedimethanol (0.65 g, 3.0 mmol), triethylamine (0.60 g, 6.0 mmol) and
dichloromethane (20 mL) was cooled in an ice bath. Thionyl chloride (0.71 g, 6.0 mmol) in dichloromethane
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(20 mL) was added into this mixture under N2 at such a rate to keep the temperature between 15-20 C. After
complete addition, the reaction mixture was kept at 20 C for 30 minutes and then stirred at 40 C for another
30 minutes. Ice was added and mixture stirred for another 5 minutes. A small amount of NaHCO3 was then
added to obtain pH 6.0. The organic layer was separated and dried over CaClz. Filtration and evaporation of
the solvent gave a dark brown solid which was dissolved in dichloromethane (20 mL) and each amino acid
(glycine, alanine, phenylalanine or tyrosine) (1.25 mmol) in dichloromethane (20 mL) was individually
added to it. The reaction mixture was refluxed for 5 h under a slow stream of N2. After allowing to cool to
room temperature solvent was evaporated to give a yellow-orange solid which was recrystallized from
chloroform.
Synthesis of Metal Complexes
Dicarboxylic acid (1.0 mmol) was dissolved in ethanol (30 mL) and warmed for several minutes. A solution
of metal (II) chloride (1.0 mmol) in ethanol (20 mL) was added to the above solution. Then 2-3 drops of conc
H2SO4 were added and mixture was refluxed for 3 h. During this time, precipitate was formed that was
filtered, washed several times with warm ethanol and diethyl ether and, then dried over anhydrous CaCI2.
Antibacterial Studies
The synthesized metal chelates in comparison to the ligands were screened for their antibacterial activity
against pathogenic bacterial strains, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa
and Klebsiella pneumonae. The paper disc diffusion method was adopted for the determination of
antibacterial activity19’2.
RESULTS AND DISCUSSION
All the synthesized dicarboxylic acids (Fig 1) are soluble in polar solvents such as methanol, ethanol and
acetonitrile, but are insoluble in weakly polar or non-polar solvents. All metal complexes dissolve only in
DMF and DMSO. All of them are amorphous solid. Molar conductance values (14-18 fcmZmol1) of the
Cu(II) complexes in DMF show them to be non-electrolytes and the values (82-90 fcmZmol") for the Co(II)
and Ni(II) complexes show all ofthem to be electrolytic in nature2.
Table 1: Physical, Spectral and Analctical Data of the Dicarboxylic acids
Dicarboxylic acid/ M.P. IR
Mol. Form. (C)
HzL C!6H20 FeN204 178
[359.85]
HL CsH26FeNzO4 165
[389.85] HzL C H FeN20, 170
H2L4 CaaHaFeN2Oa 182
[597.85]
H2L C4H42FeN20 169
[629:85]
(cm"1)
3375 (s, NH), 1822 (s, COOH),
1553 (ms, C=C)
3370 (s, NH), 1825 (s, COOH),
1550 (ms, C=C)
3372 (s, NH), 1825 (s, cooH),
1552 (ms, C=C)
3375 (s, NH), 1827 (s, COOH),
1550 (ms, C=C)
3410 (b, OH), 3380 (s, NH), 1830 r(s,
COOH), 1555 (ms, C=C)
Calc (Found %) Yield
c ia (%)
53.4 5.6 7.8 62
(53.7) (5.5)(7.3)
55.4 7.8 7.2 60
(55.3) (7.5)(7.0)
59.2 7.6 6.3 58
(58.8) (7.5)(6.8)
68.2 7.0 4.7 61
(68.6) (6.9)(4.5)
64.8 6.7 4.4 59
(65.1) (6.6) (4.6)
IR Spectra
The important infrared frequencies of the uncomplexed dicarboxylic acids and its complexes along with their
assignments are given in Tables and 3, respectively. The IR spectra of the dicarboxylic acids show
characteristic absorption bands at ~3372, ~1822 and ~1550 cm due to the v(NH), v(COOH) and v(C=C)
stretching vibrations
22 respectively. The bonding of the dicarboxylic acids to the metal atoms was
investigated by comparing IR spectra of the free dicarboxylic acids with those of their metal complexes. The
spectra of the complexes show significant changes as compared to that of the dicarboxylic acids. It can be
seen that the bands due to the v(NH) move towards lower frequency by 5-10 cm indicating their
coordination to the metal atoms through the v(NH) group. Deprotonation of the v(COOH) was also indicated
in the spectra of the complexes as the band due to the v(COO) was observed at ~1575 cm which in turn,
showed complexation through a deprotonated (COOH) group. Moreover, in the far IR region, three new
bands around 365, 415, 450 cm
1 assigned to the v(M-CI), v(M-N) and v(M-O) modes
23 respectively were
found in the spectra of the Co(lI) and Ni(II) complexes and not in the spectra of the dicarboxylic acids. The
stretches due to the v(M-N) and v(M-O) were only found in the spectra of the Cu(II) complexes, however,
bands due to the v(M-CI) in the far IR region were not found in the spectra of the Cu(II) complexes which
indicated that the Co(II) and Ni(II) complexes possess an octahedral and the Cu(II) complexes a square
planar geometry.
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Table 2: Ph,
Complex
and Anal’ ,tical Data of the Metal
Mol.Forrula M.P(C) B.M
(dec) (geff)
sCuFeNzO,t 243-245 1.5 C6H1_[421.4
2 ClHaCuFeNzO,t 248-250 1.7
--[451.4]
3 C22H2CuFeN20, 266-268 1.9
[507.4]
4 CaaHanCuFeN20 258-260 1.5
-." [659.4]
5 C,H,oCuFeN20 269-271 1.6
[691.4]
6 C6H,C1,CoFeN20, 258-260 4.3
[487.68]
7 C,.H,,C1,CoFeNzO, 248-250 4.1
[517.68]
8 C,,H,C1,CoFeNzOA 263-265 4.3
[573.68]
9 C,H,,,CI,CoFeN204 268-270 4.2
[725.68]
10 C,H,,CI,CoFeN20, 258-260 4.2
[7.57.68]
11 C,,H,C1,NiFeNzO, 259-261 2.8
[487.44]
12 C,H,,C1,NiFeN20, 262-264 3.0
[517.44]
13 C,,H,,C1,NiFeN20, 258-260 2.8
[573.44]
14 C,H,,CI,NiFeN20, 260-262 2.9
[775.44]
15 C,,H,CI,NiFeN20 258-260 2.8
[757.44]
Calc (Found)%
C H N
45.6 4.3 6.6
(45.3) (4.1) (6.8)
47.9 5.3 6.2
(48.1)(5.6)(6.3)
52.0 6.3 5.5
(52.4) (6.1) (5.5)
61.9 6:0 4.2
(62.2) (6.2) (4.0)
59.0 5.8 4.0
(59,3) (5.5)(3.8)
39.4 3.7 5.7
(39.1) (3.5).(5.8)
41.7 4.6 5.4
(41,5) (4.6)(5.1)..
46.0 5.5 4.8
(46.6) (5.4) (4.5)
56.2 5.5 3.9
(56.3)(5.0)(4.1)
53.9 5.3 3.7
(54.2) (5.2) (3.8)
39.4 3.7 5.7
(39.2) (3.6) (5.5)
41.7 4.6 5.4
(41.3) (4.7) (5.6)
46.0 5.6 4.9
(46.1) (5.6) (5.1)
56.2 5.5 3.9
(56:3) (5.4) (4..2)
53.9 5.3 3.7
(54.1) (5.3) (3.9)
NMR Spectra
The H NMR and 3C NMR spectra of the free dicarboxylic acids as well as some of their metal complexes,
taken in DMSO-d6 are listed in Table 4. The free dicarboxylic acids exhibited signals due to all the expected
protons and carbons in their expected region and have been identified from the integration curve found to be
equivalent to the total number of protons deduced from their proposed structures. These were identical to
those reported
24"28 signals of the known compounds and therefore, gave further support for the compositions
of these new dicarboxylic acids and their complexes as suggested by their IR and elemental analyses data.
When these shifts were compared to those of the corresponding complexes, they exhibited a shift of some
resonances. In each case, a broad singlet occurring downfield at 5 8.7-8.9 ppm assigned to (NH) undergoes a
shift towards higher field by 0.15-0.2 ppm in the complexes. Also, the protons due to (COOH) found in the
spectra of the dicarboxylic acids at 5 11.7-11.9 ppm suggested
29 the deprotonation of the carboxylic oxygen
atom of the dicarboxylic acids on complexation. Similarly, all other protons and carbon resonances observed
for the dicarboxylic acids shifted downfield in the spectra of their metal complexes thus showing the
complexation phenomenon to occur.
The NMR spectra of the representative Cu(II) complexes with dicarboxylic acids (L-L5) are only reported in
Table 4. The spectra of other metal complexes showed similar characteristic features except the shift (0.5-1.5
ppm) of signals and therefore, are not included in Table 4.
Electronic Spectra and Magnetic Moments
The electronic spectra of the Cu(II) complexes showed two weak low-energy bands at 15150-16355 cm and
18770-19585 cm and a strong high-energy band at 30345-31770 cm. The low-energy bands are in
positions characteristic for a square planar configuration and may be assigned to 2Big 2Ag and 2Blg -4 2Eg
transitions, respectively3’3. The strong high-energy band is assigned to metal -4 ligand charge transfer.
Also, the magnetic moment values (1.5-1.9 B.M) for the Cu(II) complexes were found to be consistent with
the proposed square planar structure (Fig 2A).
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Table 3. Spectral Data of the.Met.al Complexes
Complex IR (cm .1)
’3370.(s, NH).,.’i575 (s, Coo), 450 (m, M-O)1415 (m, M-N),
2 3375 (s, NH) 1570 (s, COO), 450 (m, M-O), 415 (m, M-N).
3 .3370 (s, NH), 1575 (S,. COO), 450 (m, M-O), 415 (m, M-N).
4 3370 (s, NH), 1575 (s, COO), 450 (m, M-O), 415 (m, M-N).
5 3370 (s, NH), 1575 (s, COO), 450 (m, M-O), 415 (m, M-N).
6 3375(s, NH),.!57.0(s, COO),450(m,M-O),415(m,M-N’),360(m,M-CI).
7 3370 (s, NH), 1575 (s, COO), 450 (m, M-O), 415 (m, M-N), 365 (m, M-CI).
8 .3375 (s, NH), 1570 (s, COO), 450 (m, M-O), 415 (m, M-N), 360 (m, M-CI).
9..3370 (s, NH), 1575 (s, COO), 450 (m, M-O),415 (m, M-N), 363 (m, M-CI).
10 3375 (s, NH), 1575.(s, COO), 450 (m, M-O), 415 (m, M-N), 360 (m, M-CI).
11. 3370 (s, NH), 1570 (s, COO), 450 (m, M-O), 415 (m, M-N), 365 (m, M-CI).
12 3370..(s,NH 1575 (s, COO),.450 (m, M-O), 415 (m, M-N), 360 (rn, M-C1).
13 3375 (s, NH), 1815 (s, COO), 450 (m, M-O), 415 (rn, M-N’), 360 (m, M-C1).
14 3370(s, NH), 1575(s, COO), 450 (m, M-O), 415 (m, M-N), 360 (m, M-CI).
15 3370 (s, NH), 1575 (s, COO), 450 (m, M-O),415 (m, M-N), 360 (m, M-CI).
s=strong, m=medium
.max (cm-1)
30345, 18770, 16355
31770,19585,15150
30865,19245,15675
30555,18990,15550
30980,19110,16275
20530r16200,7545
19500,17255,8450
20320,17160,7955
20375,16855,8225
19850, 16775, 8170
25565, 15625, 9445
26150, 15860,10315
25775, 15775, 9880
26055, 15880,10275
25880, 15822,10110
The Co(II) complexes exhibit well resolved low-energy bands at 7545-8450, 16200-17255 and a strong, high-
energy band at 19500-20530 cm
"1 assigned to the transitions 4TIg(F) 4T2(F), 4Tg(F) ---) 4A2g(F) and Tg(F)
4T2g(P) for high-spin octahedral geometry32’33. The magnetic susceptilility measurements34(4.1-4.3 B.M)
for Co(II) solid complexes are indicative of three unpaired electrons per Co(II) ion suggesting an octahedral
environment. The electronic spectra for the Ni(II) complexes show d-d bands in the region 25565-26150,
3-7 15675-15860 and 9445-10315 cm. These are assigned to the transitions AEg(F) --
TE(F), AEg(F) -+
35 T Ig(F) and A2g(F) --
T2g(P) respectively, consistent with an octahedral configuration The magnetic
measurements (2.8-3.0 B.M) were showed two unpaired electrons per Ni(II) ion suggesting
36 also an
octahedral geometry for the Ni(ll) complexes (Fig 2B).
Furthermore, a broad band centered at 22150-22500 cm" observed for every complex was assigned
3 to the
transition IAig ---) IElg in the iron atom of the ferrocenyl group indicate that there is no magnetic interaction
between the Cu(II), Co(ll) and Ni(II) ions and the diamagnetic Fe(lI) ion.
Based on the above observations, it is proposed that the Cu(II) complexes have a square planar geometry (Fig
2A) whereas the Co(II) and Ni(II) complexes are octahedral (Fig 2B).
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Fig. 2. Proposed Structure for the Cu(II), Co(II) and Ni(II) Complexes
Antibacterial Properties
The synthesized dicarboxylic acids and their metal complexes were evaluated for their antibacterial activity
against Escherichia coli (a), Pseudomonas aeruginosa (b), Staphylococcus aureus (c) and Klebsiella
pneumonae (d). The compounds were tested at a concentration of 30 lag/0.01 mL in DMF solution using the
paper disc diffusion method. The susceptibility zones measured in mm are reported in Table 5. The
susceptibility zones were the clear zones around the discs. All the dicarboxylic acids were found to be
biologically active and their metal complexes showed more significant antibacterial activity against one or
more bacterial species in comparison to the uncomplexed ligands. In most of the cases chelation tends to
make the dicarboxylic acids act as more powerful and potent bactericidal, thus killing more of the bacteria
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than the parent dicarboxylic acids. A possible explanation for the increased activity of the complexes is
proposed. It may be suggested that in the chelated complex, the positive charge of the metal is partially
shared with donor atoms and there is x-electron delocalization over the whole chelate ring. This increases the
lipophilic character of the metal chelate and favors its permeation through lipoid layers of the bacterial
membranes.
Table 4. 1H NMR and 13C NMR Data of Dicarboxylic acids and its CuI.(
1H NMR (DMSO-d6) (ppm) Dicarboxylic acid/
Complex
H2L’
H2L
H2L
H2L
H2L
3.8 (t, 4H, ferr0cenyl), 4.1 (t, 4H, ferrocnyl)i
4.4 (t, 4H, CH2N), 4.5-4.7 (m, 4H, CH2), 8.7 (s,
2H, NH), 11.7 (s, 2H, COOH).
1.7 (s, 6H, CH3), 3.7 (t, 4H, ferrocenyl), 4.3 (t,
4H, ferrocenyl), 4.5 (t, 4H, CHEN), 8.7 (s, 2H,
NH), l.7 (s, 2H, COOH).
1.6 (s, 6H, CH3), 2.2-2.3 (m, 4H, CH2), 2.4 (m,
4H, CH2), 3.8 (t, 4H, ferrocenyl CH2), 4.1 (t, 4H,
ferrocenyl), 4.5 (t, 4H, CHzN), 8.8 (s, 2H, NH),
l8 (s, 2H, COOH).
2.1 (dd, 4H, CH2), 2.3-2.5 (m, 4H, CH2), 2.5 (m,
4H, CH2), 3.7 (t, 4H, ferrocenyl), 4.2 (t, 2H,
ferrocenyl), 4.5 (t, 4H, CH2N), 8.8 (s, 2H, NH),
7.2-7.3 (m, 6H, m-H+ p-H Ph), 7.4-7.5 (m, 4H,
o-H Ph), 11.8 (s, 2H, COOH).
2.2 (dd, 4H, CH2), 2.4-2.5 (m, 4H, CH2), 2.6-2.8
(m, 4H, CH2), 3.8 (t, 4H, ferrocenyl), 4.2 (t, 2H,
ferrocenyl), 4.6 (t, 4H, CH2N), 7.3-7.4 (m, 6H,
rn-H+p-H Ph), 7.5-7.7 (m, 4H, o-H Ph), 8.9 (s,
2H, NH), 9.5 (s, .2H OH) 11.9 (s, 2H, COOH):
39 (t, 4H, ferrocenyl), 4.2 (t, 4H, ferrocenyl),
4.6 (t, 4H, CH2N), 4.6-4.8 (m, 4H, CH2), 8.6
(s, 2H, NH).
1.8 (s, 6H, CH3), 3.8 (t, 4H, ferrocenyl), 4.5 (t,
4H, ferrocenyl), 4.6 (t, 4H, CH2N), 4.7-4.8 (m,
4H, CH2), 8.5 (s, 2H, .NH).
1.8 (s, 6H, CH3), 2.3-2.4 (m, 4H, CH2), 2.6-2.8
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl CH2), 4.3 (t,
4H, ferrocenyl), 4.7 (t, 4H, CHEN), 8.5 (s, 2H,
NH).
2.3 (dd, 4H, CH2), 2.4-2.5 (m, 4H, CH2), 2.6-2.7
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl), 4.3 (t, 2H,
ferrocenyl), 4.6 (t, 4H, CHzN), 8.6 (s, 2H, NH),
7.3-7.4 (m, 6H, m-H+ p-H Ph), 7.6-7.9 (m, 4H,
o,H Ph).
2.3 (dd, 4H, CH2), 2.5-2.6(m, 4H, CH2), 2.8-2.9
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl), 4.3 (t, 2H,
ferrocenyl), 4.8 (t, 4H, CHzN), 7.4-7.5 (m, 6H,
rn-H+p-H Ph), 7.7-7.8 (m, 4H, o-H Ph), 8.5 (s,
2H, NH), 9.8 (s, 2H, OH).
4.0 (t, 4H, ferrocenyl), 4.3 (t, 4H, ferrocenyl),
4.8 (t, 4H, CH:N), 4.5-4.8 (m, 4H, CH2), 8.7 (s,
2H, NH).
1.9 (s, 6H, CH3), 4.0 (t, 4H, ferrocenyl), 4.4 (t,
4H, ferrocenyl), 4.8 (t, 4H, CH2N), 4.8-5.0 (m,
4H, CH2), 8..7. (s, 2H, NH).
2.0 (s, 6H, CH3), 2.4-2.6 (m, 4H, CH2), 2.8-2.9
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl CH2), 4.5 (t,
4H, ferrocenyl), 4.8 (t, 4H, CHEN), 8.7 (s, 2H,
NH).
2.4 (dd, 4H, CH2), 2.6-2.9 (m, 4H, CH2), 3.0-3.2
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl), 4.5 (t, 2H,
ferrocenyl), 4.8 (t, 4H, CH2N), 8.7 (s, 2H, NH),
7.4-7.6 (m, 6H, m-H+ p-H Ph), 7.9-8.1 (m, 4H,
o-H ph).
Complexes
---’r3"IR (DMSO-d6) (ppm)
69.5, 83.7 (ferrocenyl), 176.8
22.5 (CH3), 38.1 (Fc.CH2), 54.8
(CH), 68.5, 69.5, 83.7 (ferrocenyl),
!76.
22.5 (CH3), 38.2 (Fc.CHz), 43.1,
42.4 (CH2), 54.9 (CH), 68.7, 69.6,
83.7 (ferrocenyl), 176.8 (COOH).
38.1 (Fc.CHz), 43.2, 42.4, 42.8
(CH2), 54.9 (CH), 68.7, 69.5,
83.7 (ferrocenyl), 129.0, 130.7,
134.1 (Ph), 176.7 (COOl-I).
38.1 (Fc.CH2), 43.2, 42.4, 42.8
(CH2), 54.9 (CH), 68.5, 69.5,
83.7 (ferrocenyl), 129.1, 130.8,
134.5, 138.2 (Ph), 176.8 (COOH).
38.3 (Fc.CH2), ’50.’ (NCH2),
68.8, 69.5, 83.8 (ferrocenyl)
173...5 .(COO).
22.7 (CH3), 38.2 (Fc.CH2),
50.6 (CH), 68.8, 69.6, 83.8
Ife0cenyl).. !.7.3:7 (COO).
22.8 (CH3), 38.4 (Fc.CH),
43.2, 42.5 (CHz), 54.9 (CH),
68.8, 69.8, 83.9 (ferrocenyl),
1..73.6 (COO).
38.3 (Fc.CH2), 43.3, 42.4, 42.9
(CH), 54.9 (CH), 68.8, 69.7,
83.8 (ferrocenyl), 129.1, 130.9,
134.3 (Ph), 173.7 (COO).
38.2 (Fc.CH2), 43.4, 42.6, 429
(CH2), 54.9 (CH), 68.7, 69.6,
83.9 (ferrocenyl), 129.2, 130.9,
134.7, 138.4 (Ph), 173.8 (COO).
3850:7 (NCH)I
68.9, 69.7, 83.7 (ferrocenyl)
22.9 (ell3), 38.4 (Fc.CI-I_), 50.7
(CH), 68.9, 69.8, 83.8 (ferrocenyl).
22.9 (CH3), 38.6 (Vc.CH;), 43.3;
42.7 (CH2), 54.9 (CH), 69.1,
69.9, 83.9 (ferrocenyl), 173.7
(coo).
38.4 (Fc.CHz), 43.6, 42.5, 43.0
(CHz), 55.0 (CH), 68.8, 69.8,
83.9 (ferrocenyl), 129.2, 130.0,
134.5 (Ph), 173.9 (COO).
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10
11
12
13
14
15
2.4 (dd, 4H, CH2), 2.6-2.9(m, 4H, CH2), 3.1-3.2
(m, 4H, CH2), 4.0 (t, 4H, ferrocenyl), 4.4 (t, 2H,
ferrocenyl), 4.9 (t, 4H, CHzN), 7.5-7.6 (m, 6H,
m-H+p-H Ph), 7.8-8.0 (m, 4H, o-H Ph), 8.6 (s,
2H, NH), 9.9 (s, 2H OH).
4.1 (t, 4H, ferrocenyl), 4.4 (t, 4H, ferrocenyl),
4.7 (t, 4H, CHzN), 4.8-4.9 (m, 4H, CH2), 8.7 (s,
2H, NH).
1.9 (s, 6H, CH3), 4.0 (t, 4H, ferrocenyl), 4.4 (t,
4H, ferrocenyl), 4.3 (t, 4H, CHzN), 4.5-4.7 (m,
4H, CH), 8.2 (s, 2H, NH).
1.5 (s, 6H, CH3), 2.1-2.3 (m, 4H, CH2), 2.7-2.9
(m, 4H, CH2), 3.5 (t, 4H, ferrocenyl CH2), 4.0 (t,
4H, ferrocenyl), 4.8 (t, 4H, CHaN), 8.2 (s, 2H,
NH).
2.1 (dd, 4H, CH2), 2.3-2.5 (m, 4H, CH2), 2.7-2.9
(m, 4H, CH2), 3.9 (t, 4H, ferrocenyl), 4.1 (t, 2H,
ferrocenyl), 4.5 (t, 4H, CHzN), 8.7 (s, 2H, NH),
7.1-7.3 (m, 6H, m-H+ p-H Ph), 7.7-7.9 (m, 4H,
o-H Ph).
2.0 (dd, 4H, CH2), 2.2-2.4(m, 4H, CH2), 2.8-2.9
(m, 4H, CH2), 3.8 (t, 4H, ferrocenyl), 4.2 (t, 2H,
ferrocenyl), 4.6 (t, 4H, CHzN), 7.2-7.5 (m, 6H,
m-H+p-H Ph), 7.8-7.9 (m, 4H, o-H Ph), 8.3 (s,
2H, NH), 9.9 (s, 2H, OH).
38.4 (Fc.CH2), 43.6, 42.8, 42.9
(CH2), 54.9 (CH), 68.8, 69.7,
83.9 (ferrocenyl), 129.3, 130.9,
134.9, 138.5 (Ph), 173.9 (COO).
38.3 (Fc.CH2), 50.6 (NCH2),
68.8, 69.5, 83.8 (ferrocenyl)
173.5 (COO).
22.7 (CH3), 38.2 (Fc.CH2),
50.6 (CH), 68.8, 69.6, 83.8
(ferrocenyl). 173.7 (COO).
22.8 (CH3), 38.4 (Fc.CH2), 43.2,
42.5 (CH2), 54.9 (CH), 68.8, 69.8,
83.9 (ferrocenyl), 173.6 (COO).
38.3 (Fc.CH2), 43.3, 42.4, 42.9
(CH2), 54.9 (CH), 68.8, 69.7,
83.8 (ferrocenyl), 129.1,130.9,
134.3 (Ph), 173.7 (COO).
38.2 (Fc.CH2), 43.4, 42.6, 42.9
(CH2), 54.9 (CH), 68.7, 69.6,
83.9 (ferrocenyl), 129.2, 130.9,
134.7, 138.4 (Ph), 173.8 (COO).
Table 5. Antibacterial Activity Data
"Dicarboxylic acid/ M c r o
Complex
.H2L ’."’ H..2.L
H2L
HzL
4
++
7
++
+++
+++
+++
4 +++
5 ++++
6 +++
++++
8 ++
9 +++
10
11
12
+++
15
+++
+++
b ial S pecies
b c d
+ + ++
+ ++ +
+ + ++
++ +
+ + ++
++ +++
+++
+++
++
+++
++
++++ ++
++ ++ +++
+++ +++ +++
+++ +++ ++
++ +++ +++
+++ + ++++
+++ +++ ++
+++
++
+++
+++
+++
++++
+++
+++
++
13 ++ +++ ++ +++
14 ++ +++ +++ ++
+++ ++ ++ +++
a Escherichia coli,
c Pseudomonas aeruginosa
b Staphylococcus aureus,
d Klebsiella pneumonae
Inhibition zone diametermm (% inhibition): +, 6-10 (27-45 %); ++, 10-14
(45-64 %); +++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values are
relative to inhibition zone (22 mm) of the most active compound with 100 % inhibition.
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